Arbutus Biopharma Corp
ABUSNasdaqCIK 1447028HealthcareFiscal year ends Dec 31
Reports and events: 561 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2011-04-0513:15 ET | 6-K | Report of a foreign private issuerPeriod 2011-04-04 | 0001193125-11-088752 |
| 2011-03-3113:16 ET | 6-K | Report of a foreign private issuerPeriod 2011-03-30 | 0001193125-11-084022 |
| 2011-03-3013:16 ET | 6-K | Report of a foreign private issuerPeriod 2011-03-30 | 0001193125-11-082188 |
| 2011-03-1714:18 ET | 6-K | Report of a foreign private issuerPeriod 2011-03-17 | 0001193125-11-069572 |
| 2011-01-1022:27 ET | 6-K | Report of a foreign private issuerPeriod 2011-01-10 | 0001193125-11-005239 |
| 2010-12-2217:29 ET | 6-K | Report of a foreign private issuerPeriod 2010-12-22 | 0001193125-10-286327 |
| 2010-11-2221:43 ET | 6-K | Report of a foreign private issuerPeriod 2010-11-22 | 0001193125-10-266437 |
| 2010-11-1719:21 ET | 6-K | Report of a foreign private issuerPeriod 2010-11-17 | 0001193125-10-262880 |
| 2010-11-1601:30 ET | 6-K | Report of a foreign private issuerPeriod 2010-11-15 | 0001193125-10-261134 |
| 2010-11-1521:05 ET | 6-K | Report of a foreign private issuerPeriod 2010-11-15 | 0001193125-10-260623 |
| 2010-11-1220:32 ET | 6-K | Report of a foreign private issuerPeriod 2010-11-12 | 0001193125-10-258726 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.